Azza M. Abdel-Latif

Azza M. Abdel-Latif

Auto-generated profile, based on publicly available information

Azza M. Abdel-Latif

Division of Human Genetics & Genome Research; Department of Molecular Genetics and Enzymology, National Research Centre, 33 Bohouth St. Dokki, Giza, Egypt

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
NINabaweya A. Ibrahim
Nabaweya A. Ibrahim
FEFatma S. El-Sakhawy
Fatma S. El-Sakhawy
MMMagdy M. D. Mohammed
Magdy M. D. Mohammed
MFMohamed A. Farid
Mohamed A. Farid
NANayera A.M. Abdel-Wahed
Nayera A.M. Abdel-Wahed
DDDoaa A.H. Deabes
Doaa A.H. Deabes

18 March 2015 in Journal of Negative Results in BioMedicine
Verified
Journal Article
Open access
PDF file
NBNeda Bogari
Neda Bogari
AAAzza M Abdel-Latif
Azza M Abdel-Latif
MHMaha A Hassan
Maha A Hassan
ARAbeer Ramadan
Abeer Ramadan
AFAhmed Fawzy
Ahmed Fawzy
Several environmental and genetic factors are associated with high levels of lipids in obese patients. Apolipoprotein B (ApoB) is the major protein component of low-density lipoproteins (LDL), very-low density lipoproteins (VLDL) and chylomicrons and plays a central role in lipid metabolism. Several apoB restriction fragment length polymorphisms (XbaI, EcoRI, MspI) have been reported to be associated with variation in lipid levels and obesity. To date, no data are available on the relationship between XbaI polymorphism and lipid levels in Egyptian populations. Following clinical profiling, 178 obese (body mass index [BMI] >25 kg/m2) and 178 age-matched non-obese (BMI ≤ 25 kg/m2) subjects were included in this case–control study. All samples were analysed for total cholesterol, triglycerides and HDL-cholesterol. Genetic analysis of apoB XbaI (X) was performed using Polymerase Chain Reaction-Restriction Fragment Length polymorphism (PCR-RFLP). The aim of this study was to assess the association of apoB XbaI gene polymorphism (X) and lipid profiles in obese and non-obese Egyptian populations. Obese subjects demonstrated significantly higher values of waist-to-hip ratio, blood pressure, and total lipid. However, in our sample we did not find significant differences in apoB XbaI gene polymorphism (X) genotype or allele frequencies. Moreover, none of the studied lipid parameters showed any association with the gene polymorphism. This study reveals no significant association of apoB XbaI gene polymorphism (X) with obesity or lipid profiles in an Egyptian population.

1 September 2015 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
NBNeda Bogari
Neda Bogari
HRHusni H. Rayes
Husni H. Rayes
FMFakri Mostafa
Fakri Mostafa
AAAzza M. Abdel-Latif
Azza M. Abdel-Latif
ARAbeer Ramadan
Abeer Ramadan
AFAhmed Fawzy
Ahmed Fawzy

1 December 2014 in Biochemistry Letters
Verified
Journal Article
Open access
PDF file
GEGhada El-Feki
Ghada El-Feki
MEMohamed ali El-desouky
Mohamed ali El-desouky
MBMohamed A. Badway
Mohamed A. Badway
AAAzza M. Abdel-Latif
Azza M. Abdel-Latif
MHMaha A. Hassan
Maha A. Hassan
AFAhmed Fawzy
Ahmed Fawzy
Background: Dipeptidyl Peptidase I (DPPI) is one of the essential components which initiate chain reaction for triggering the inflammatory response mediated allergic diseases such as asthma. Previous studies have reported that several mutations have been detected within the dipeptidyl peptidase I gene (CTSC) cause Papillon-Lefévre syndrome. It has been suggested that a mutation in this gene could give protection against the inflammatory response in allergic diseases. The aim of this study was to investigate wither the polymorphism (rs217086 (T153I)) in the gene for DPPI may be protective in asthma. Methods: To examine possible associations of DPP1 polymorphism with asthma susceptibility, we performed this study. 341 families with at least two siblings with asthma were genotyped for a CTSC polymorphism using high resolution melting curve analysis. Genetic association analysis was analysed using family based association tests (FBAT) and resultant called genotypes were sequenced. Results: DNA sequence data confirmed all variant genotypes. Analysis by FBAT showed no significant association between this polymorphism and asthma susceptibility or with any of asthma-related phenotypes tested. Conclusions: Our data proved that DPPI does not contribute substantially to susceptibility for asthma. Further studies examining both genotypes and environmental factors will be necessary to elucidate the role of DPPI in the development of allergic diseases.